Back

Nationwide analysis of mortality trends in dyslipidemia and peripheral artery disease in the United States of America: a two-decade study of demographic and geographic disparities

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Trends in peripheral artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Abdullah Hilal Zafar

Royal Albert Edward Infirmary, Wigan (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
The association of aortic and iliac calcification with aortic events, peripheral revascularization and amputation: a DANCAVAS substudy
Ms Z. Karon (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Impact of lipid-rich plaques in femoropopliteal artery on limb outcomes in patients receiving endovascular therapy
Assistant Professor Y. Sato (Fukui, JP)
Abstract Slides Video
Presentation thumbnail
Risk Factors for myocardial infarction in patients with peripheral artery disease
Professor K. Keller (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Impact of guideline-directed medical therapy on outcomes in patients with peripheral arterial disease: a multicenter prospective study
Doctor P. Chen (Tainan, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Trends in peripheral artery disease

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Regional and demographic variations in diabetes mellitus and myocardial infarction mortality among US adults: a retrospective observational analysis from 1999-2023
thumbnail
Congress Presentation
Valvular heart disease vs. coronary artery disease: a comparative mortality analysis of long-term outcomes using CDC WONDER (1999-2020)
thumbnail
Congress Presentation
Sudden cardiac death vs. myocardial infarction: analyzing age and racial disparities in mortality trends using CDC WONDER

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources